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Biologically inspired oxidation catalysis using
metallopeptides
Laia Vicens and Miquel Costas *
The stereoselective oxidation of hydrocarbons is one of the most challenging reactions for synthetic che-
mists. However, this transformation is one of the most common reactions in nature. Metalloenzymes that
catalyze this transformation are taken as inspiration for the development of new catalysts. There are
several examples in the literature where either peptides or metal catalysts are used in the stereoselective
oxidation reaction, but the synergistic combination of both systems is still a non-explored ﬁeld. The use of
metallopeptides in biologically inspired oxidation reactions is discussed in this perspective.
Introduction
Reactions of selective oxidation are important in organic syn-
thesis because oxygenated hydrocarbon chains are ubiquitous
in organic molecules of relevance in pharmaceutical chemistry
and biochemistry. Eﬃcient preparation of these molecules
requires the development of novel oxidation methodologies
operating with high levels of chemo, regio and stereo-
selectivity. These methods should exhibit high atom economy
and need to be based in earth abundant elements. These
aspects make these systems more sustainable than current
methodologies. Catalytic methods operating under mild
conditions and using first row transition metals and benign
oxidants such as O2 and H2O2 are particularly appealing.
1
Selective oxidation is common in nature. Metalloenzymes
catalyze a large variety of reactions with high eﬃciency
using mild conditions,2 and one of the most distinctive and
valuable aspects of enzymatic reactions is their high selectivity
in terms of chemo, regio and stereoselectivity. Key to this
selectivity is the highly elaborated structure of the enzyme
active site.3 In the enzyme active site the metal is ligated by
amino acid residues, which are key to define its reactivity.
Moreover, large polypeptide chains define elaborated second
sphere structures, creating a cavity that embeds the metal and
defines a three-dimensional network of chemical functional-
ities that can engage in non-covalent interactions with the sub-
strate. These interactions determine the proper orientation of
the substrate in the enzyme active site, and may also activate or
deactivate specific substrate sites. These factors translate into
highly selective oxidative transformations.4 Furthermore, due to
the inherent chirality of amino acids, proteins contain chiral
active centers, susceptible to highly stereoselective oxidations.
Enzymes thus constitute paradigmatic evidence that pep-
tides can endow catalytic metal centers with extraordinary
selectivity properties and constitute an inspiration motif to
develop synthetic metal based oxidation catalysts. Along these
lines, the combination of peptides and metal ions can be
viewed as a powerful strategy to create artificial catalysts. In
this approach, it is envisioned that the high reactivity of
metals can be combined with the high structural and func-
tional group versatility of peptides, ideally translating into
reactive and selective catalysts.
Despite the combination of peptides and metal catalysts
is a promising platform to be used in oxidative transform-
ations, examples in the literature still remain scarce, presum-
ably because peptides and metal catalysts may be expected to
face compatibility problems. These examples are discussed in
the following sections. In contrast, peptides have been actively
explored as oxidation organocatalysts, and highly stereo-
selective transformations have been described. These studies
are particularly interesting because they have delineated
mechanisms to govern the regio and stereoselectivity in oxi-
dation reactions, which ideally will be very interesting to
implement in metal catalyzed reactions. These reactions are
therefore of fundamental interest in the design of metal based
catalysts, and have also been briefly discussed.
Organocatalysis
Organic chemists have used small peptides (<50 amino acids)
as catalysts for a number of asymmetric transformations,
including oxidations.5 Despite a limited number of commonly
used amino acid residues, they can be combined in a large
number of diﬀerent sequences to produce a variety of second-
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ary structures. This oﬀers a powerful tool to rapidly create cata-
lyst diversity, a key factor to pursue tunable selectivity
(specially stereoselectivity).4b,5,6 Moreover, the reactivity of pep-
tides can be easily tuned by modifying a single amino acid
residue of the chain.6b
In the specific field of oxidation reactions, most of the
studies described so far have focused on asymmetric epoxi-
dation reactions.7 Relevant examples are described in the fol-
lowing lines, and the mechanisms that govern selectivity are
briefly discussed (Scheme 1).
Probably the best well-known enantioselective catalyzed oxi-
dation reaction is the Juliá–Colonna epoxidation, discovered
and developed in the early eighties.8 The reaction relies on the
use of poly-(amino acids) as catalysts, and provides excellent
enantioselectivities (up to 97% in 24–48 h) in the epoxidation
of chalcones (Scheme 1A). Several advances have been sub-
sequently made, including the modification of the original
reaction conditions and of the structure of the catalysts, which
have broadened the substrate scope.9
This reaction proceeds via the addition of hydroperoxide
over the β carbon in the substrate, generating an enolate that
subsequently displaces a hydroxide through an intramolecular
nucleophilic attack.10 Stereoselectivity in the attack relies on
the relative positioning of the substrate and the peroxide
resulting from a network of hydrogen bond interactions
between the oxygen atoms of the peroxide, and of the substrate
with the N–H groups of the peptide (Fig. 1).11
Peptides have also been used in the electrochemical oxi-
dation of sulfides. The most successful strategy is the use of
peptide-coated electrodes. Komori and Nonaka showed that
platinum electrodes double-coated with polypyrrole and poly-L-
valine provided the best results, allowing the preparation of
sulfoxides in moderate to good yields and good to excellent
enantioselectivities (Scheme 1B).12
More elaborated peptides have been explored by Miller and
co-workers, who developed an aspartate-derived peptide cata-
lyst that epoxidizes 1-substituted carbamates with enantio-
selectivities up to 92% (Scheme 1C).13 Using aqueous H2O2 or
urea hydrogen peroxide (UHP) as an oxidant, a peracid inter-
mediate is generated in situ (Fig. 2, 3a), which is responsible
for the oxidation of olefins. Of note, this represents the first
example of a highly enantioselective electrophilic epoxidation
using a peptide catalyst.
The authors proposed that the epoxidation is directed by
H-bonding interactions that occur between this intermediate
and the carbamate moiety of the substrate (Fig. 2, 3b). In
Scheme 1 Representative examples of peptide-based organocatalytic systems applied in oxidation reactions.
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accordance with this proposal, when this functionality is not
present in the molecule, the enantioselectivity decreases sub-
stantially (10% ee in the epoxidation of 1-phenyl-1-cyclohex-
ene). These data, together with other mechanistic studies,14
reveal that these non-covalent interactions between the
peptide and the olefin are key to define the stereoselectivity of
the reactions.
Other aspartate-derived peptide catalysts have also been
applied in the selective asymmetric epoxidation of polyenes,15
the enantioselective epoxidation of allylic alcohols16 and the
enantioselective oxidation of indoles.17 In these examples, the
structure of the peptide plays a crucial role in dictating the
selectivity of the reactions due to the diﬀerent non-covalent
interactions that occur between the catalyst and the substrate.
This fact is clearly demonstrated in the case of the epoxidation
of polyenes.15 Through a combinatorial approach, the authors
reported a peptide (Fig. 3A, 5) that epoxidizes 1-farnesol and
other polyenes with high regioselectivity towards the 2,3-posi-
tion and also with high enantioselectivity (86% ee). These
results are comparable with those obtained with the Sharpless
catalyst.18 Since no reaction is observed when the alcohol
moiety of the olefin is substituted by a methyl ether, it is pro-
posed that the hydroxyl group of the substrate interacts with
the peptide, directing the selectivity of the reactions. The
authors also found a peptide (Fig. 3A, 6) that shows regio-
selectivity towards the 6,7-position, but only low enantio-
selectivities were observed (10% ee). This loss of enantio-
selectivity is attributed to a high number of rotational bonds
between the hydroxyl group and the double bond, since the
olefin is located in a more remote position (Fig. 3B).
The same authors reported, in 2012, a new type of peptide
for asymmetric epoxidation.19 In this case, a dioxirane was
transiently generated (Fig. 4, 4a). This intermediate was cataly-
tically active and yields high enantioselectivities in the epoxi-
dation of aryl-substituted alkenes (Scheme 1D). It is proposed
that in the transition state (Fig. 4, 4b) the peptide adopts a
conformation that minimizes the allylic strain between the
amide and the trifluoroketone center and the substrate may
interact with the peptide by locating the smallest substituent
of the alkene (H) near the largest dioxirane substituent (CF3).
The oxygen of the oxirane can then interact with the double
Fig. 2 Peracid intermediate generated in the peptide (3a) and hypothe-
tical transition state for the asymmetric epoxidation of cyclohex-1-en-1-
ylmethylphenylcarbamate (see Scheme 1C), consistent with the absolute
conﬁguration of the major epoxide (3b). Adapted from ref. 13.
Fig. 3 (A) Regioselective epoxidation of farnesol using diﬀerent pep-
tides. (B) Possible model that justiﬁes the selectivity towards the 6,7-
position. Adapted from ref. 15b.
Fig. 1 Schematic representation of the interaction between poly-
leucine 1 and chalcone. The methyl groups of the side chain of the
amino acids have been omitted for clarity. Adapted from ref. 11b.
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bond due to the overlap between the lone pairs on the oxygen
atom with the π* orbitals of the double bond.
Overall, these studies demonstrate the ability of peptides to
govern stereoselectivity in oxidation reactions on the basis of a
combination of a series of weak interactions between the
peptide with the oxidant and the substrate. Particular limit-
ations of these reactions are the need for relatively large cata-
lyst loadings and long reaction times, aspects that a priori may
be addressed by introducing highly reactive metal ions.
Metallopeptides
The combination of peptides and metal catalysts has been
used in several asymmetric transformations such as hydrosilyl-
ation,20 cyclopropanation,21 allylic alkylation,22 conjugate
additions to enones23 and addition of cyanides to aldehydes
(Strecker reaction),24 among others.25 However, a few examples
of the use of metallopeptides as catalysts in oxidation reac-
tions have been reported, and moreover, all of them are
applied in the asymmetric epoxidation of olefins.
In 1992, Inoue and co-workers reported the catalytic asym-
metric epoxidation of allylic alcohols using titanium metallo-
peptides.26 In a similar way as in the Katsuki–Sharpless epoxi-
dation,27 titanium alkoxides are used in this system. However,
the tartrates that are used as partners were substituted by
dipeptides whose amino terminal site is modified to a pheno-
lic Schiﬀ base (Fig. 5). Although this system does not improve
the results obtained by Sharpless, it represents a pioneering
example in the field of metallopeptides.
This system, previously tested in the asymmetric synthesis
of cyanohydrins,6a was used as a catalyst in the epoxidation of
nerol using TBHP as an oxidant at −20 °C in the presence of
10 mol% of a mixture formed by equimolar quantities of Ti
(OiPr)4 and Nap-S-Val-S-Phe-OMe (7), which was the most
eﬃcient peptide in the synthesis of cyanohydrins. The corres-
ponding epoxide was obtained, even though only low enantio-
selectivities (13% ee) were achieved. However, modifying the
structure of the peptide or even using only one amino acid and
using 1,1-diphenylethyl hydroperoxide (DPEHP) as an oxidant
instead of TBHP, the enantioselectivity increases up to 66% ee
(Scheme 2A). This methodology allows the asymmetric epoxi-
dation of several allylic alcohols in good yields and enantio-
selectivities (Scheme 2B).
In 1999, Jacobsen and co-workers reported that the combi-
nation of metal ions and peptides can be eﬀective in the asym-
metric epoxidation of trans-β-methylstyrene.28 The structure of
the ligands was based on a chiral peptide chain that contains
some moieties that can interact with the metal center. It was
envisioned that this structure would create a binding pocket
accessible for the metal ions.
To design selective epoxidation catalysts, the authors used
an elegant combinatorial chemistry approach (Fig. 6). Five
diﬀerent amino acids that present side chains with electron-
Fig. 4 Dioxirane intermediate generated in the peptide (4a) and
hypothetical transition state for the asymmetric epoxidation of an oleﬁn,
consistent with the absolute conﬁguration of the major epoxide (4b).
Adapted from ref. 19.
Fig. 5 Representative ligands used in the work of Inoue and co-workers.
Scheme 2 (A) Asymmetric epoxidation of nerol catalysed by the Ti-9
complex. (B) Substrate scope for this methodology.
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donor character (A, B, C, D and E in Fig. 6) were attached to a
polystyrene-based support. To these blocks, three linking
elements were attached. A salicylimine ligand was also pre-
pared, resembling the well-known salen-type ligands,29 highly
eﬀective for asymmetric epoxidation. Finally, 12 diﬀerent end
capping agents incorporating diﬀerent heterocycles were
attached to the previous 16 structures, generating a total of
192 ligands, which were combined with a series of 30 metal
ion sources.
A three-step procedure was then applied to identify
eﬃcient epoxidation catalysts from all the 5760 metal–ligand
complexes synthesized. In the first step, the full library was
tested in the epoxidation of trans-β-methylstyrene and
the conditions of the reaction were optimized. The use of
H2O2 as oxidant in combination with a mixture of dichloro-
methane and tert-butanol as solvent was found to be the
best conditions. In the second step, a total of 30 sub-libraries
were prepared, each containing a mixture of all 192 ligands
and a metal source. It was observed that libraries containing
FeII centers were the most active ones, in particular the
library that contains FeCl2. Finally, in the third step the
ligand components needed for the catalytic activity were
determined by preparing 12 diﬀerent sub-libraries, each con-
taining the 16 basic structures with a unique ending cap. The
results obtained showed that the most active libraries were
those containing a pyridine moiety.
The enantioselectivity of the reaction was determined in the
asymmetric epoxidation of trans-β-methylstyrene using the
three most active complexes (Scheme 3A) however only low ee
values were obtained (up to 7% ee). To improve the enantio-
selectivity of the catalysts, a parallel library was synthesized
and three new structures were identified as eﬃcient catalysts
(Scheme 3B), obtaining the epoxide in up to 78% yield and
20% ee when 13 was used. This system reported by Jacobsen
and co-workers constitutes also a pioneering work of the use
of metallopeptides in oxidation reactions. Surprisingly,
although the potential of peptides to be combined with metal
centers is demonstrated, this field has not been further
developed.
This work is one of the first examples of non-heme iron
catalyzed asymmetric epoxidation using H2O2 as the oxidant.
However, the levels of stereoselection and the activity of the
Fig. 6 Schematic representation of the synthesis of the library following a combinatorial approach.
Scheme 3 Metal–ligand complexes that present the highest activity in
the asymmetric epoxidation of trans-β-methylstyrene.
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catalysts were modest. It can be reasoned that the peptides
employed are quite flexible, and contain several potential
binding sites. Therefore, the peptides employed in this work
do not provide a unique, rigid, and well-defined coordination
sphere around the metal. Instead, binding of the peptide to
the metal may result in multiple and distinct catalytically
active species. In the following years there has been an increas-
ing understanding of the key elements in the coordination
chemistry architecture of iron complexes that are necessary to
create eﬃcient oxidation catalysts.30 Novel generations of iron
and manganese coordination complexes, which contain rigid
and oxidatively robust tetradentate ligands, have been
described to activate H2O2 via paths that resemble those oper-
ating in O2 activating enzymes, furnishing high product yields
and enantioselectivities in C–H oxidation,31 epoxidation32 and
syn-dihydroxylation.33
A synergistic combination of one of these catalysts with
peptides has been recently described to create a highly
enantioselective epoxidation catalytic system.34 In this work,
peptides were employed with the aim to shape the second
coordination sphere of the metal and also to establish non-
covalent interactions with the substrates.4b,6b These features
were envisioned to play an important role in defining the reac-
tivity of the metal center and the chemo- and regioselectivity
of the reactions.
In this work, the iron complex (S,S)-[Fe(OTf)2(
Me2Npdp)]
(15), was employed as a catalyst. It was previously shown that
this catalyst activates hydrogen peroxide eﬃciently employing
catalytic amounts of a carboxylic acid,32e and even an amino
acid, as co-catalysts.32i Taking advantage of this feature, pep-
tides with a terminal carboxylic acid were used as co-catalysts.
Diﬀerent peptides were tested in combination with 15 in
the asymmetric epoxidation of α-methylstyrene, which was
taken as a model substrate (Scheme 4). It was found that these
systems were able to activate hydrogen peroxide and epoxidize
the olefin with excellent chemoselectivity. Interestingly, pep-
tides did not alter the reactivity of the catalyst and were not
oxidized under the experimental conditions, proving a remark-
able compatibility. From the screening of peptides, there were
diﬀerent features that were found to be crucial to obtain high
enantioselectivities.
(i) The enantiomeric ratio of the product is sensitively
dependent on the relative chirality of the metal catalyst and
the peptides. Matching–mismatching eﬀects resulting from
the combination of the two chiralities were observed for a
number of peptides, indicating that the peptide can play a
crucial role in dictating the enantioselectivity of the oxi-
dations, and that synergistic eﬀects between the metal catalyst
and peptide can be induced.
(ii) The position of the carboxylic acid in the structure of
the peptide also plays an important role in determining the
selectivity of the reactions, as diﬀerent enantioselectivities
were observed when peptides with identical structures except
for the position of the carboxylic acid moiety were used (16 vs.
17 and 18 vs. 19 in Scheme 4). These observations, in combi-
nation with the results obtained in previous studies on the
activity of non-heme iron catalysts with simple carboxylic
acids;32c,e,35 suggest that the peptide acts as a ligand, likely via
the carboxylic acid moiety.
(iii) Peptides that present a flexible backbone provide worse
enantioselectivities than those obtained with more rigid pep-
tides. The β-turn structure that the peptide adopts seems to be
important to improve the stereoselectivity of the reactions,
however the identification of structure–activity correlations is
Scheme 4 Diagrams of representative peptides studied in the asym-
metric epoxidation of α-methylstyrene catalysed by 13 and enantio-
selectivities obtained. For each peptide, the dark grey bar corresponds
to the ee obtained with (S,S)-15 while the light grey bar corresponds to
the ee obtained with (R,R)-15.
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diﬃcult due to the high complexity of the peptides tested by
the authors, and because the number of peptides examined is
relatively small.
All the set of reactions tested allows the identification of
compound 21 as the best peptide within the series tested,
which was subsequently studied in the asymmetric epoxi-
dation of diﬀerent α-methylstyrene derivatives (Scheme 5), sub-
strates that are particularly challenging for current epoxidation
technologies.32i,36 Moderate enantioselectivities were obtained
with meta-, para- and non-substituted derivatives, but the
values increase when ortho-substituted α-methylstyrene deriva-
tives were tested, obtaining up to 92% ee.
Diﬀerent control experiments demonstrated the synergistic
cooperation of the peptide and the metal catalyst in the acti-
vation of hydrogen peroxide and also in the highly chemo- and
enantioselective oxygen atom transfer to the olefin.
In summary, it was also concluded that the carboxylic acid
group of the peptide connects the metal center to the amino
acid chain of the peptide, which is then defining the second
coordination sphere around the metal (Fig. 7). Therefore, this
system can be considered as an approach towards the design
of artificial oxygenases.
The strategy described in this work relies on the accurate
control of the first coordination sphere around the metal. At
the same time, it also represents a promising platform for
the rapid identification of peptides that will improve the
enantioselectivity of previously described iron catalysts.
However, this approach presents some weak points. Most
importantly, the metal catalysts and the peptide are exclu-
sively connected via the carboxylic acid moiety, so their
interaction is non-directional. Therefore, this catalyst–
peptide system is structurally very flexible, which can be
considered as a drawback for favoring the selectivity of the
system on the basis of specific interactions between the
peptide and the substrate, which in turn must result in
dominant catalyst–substrate relative orientations.
Furthermore, the current study is based on unfunctionalized
substrates, which are very unlikely to engage in weak inter-
actions with the peptide, and therefore the selectivity role of
the peptide may be almost exclusively based on steric inter-
actions. Studies with substrates containing polar groups sus-
ceptible to engage in weak interactions such as H-bonding
or electrostatic and hydrophobic interactions may represent
an attractive future avenue.
Conclusions and outlook
In summary, metallopeptides have been used as catalysts in
several asymmetric reactions, but only very few examples are
applied so far to oxidation reactions. The current studies show
that peptides appear to be compatible with oxidation catalysis
and thus they can represent a valuable choice for ligand
design. It is envisioned that the rich architecture of peptides,
readily accessible via standard peptide synthesis method-
ologies, may allow introducing high structural versatility in
metal oxidation catalysts, endowing the metals with high
selectivity properties. The use of weak interactions between the
substrate and peptides is expected to enable selectivities that
are still inaccessible with the current synthetic methods used
in organic synthesis, thus expanding the substrate scope of the
reactions.
Overall, metallopeptides may become a powerful tool in the
development of new catalytic systems for bioinspired oxidation
reactions, a field in which metallopeptides have rarely been
used. The combination of metal catalysts and peptides would
combine the potential of both systems, which can suppose an
important step towards the development of novel oxidation
technologies with utility in organic synthesis.
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Scheme 5 Representative examples of the substrate scope for this
system.
Fig. 7 Schematic representation of the interaction between the peptide
and the metal catalyst.
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